Journal of Clinical Endocrinology & Metabolism, Vol 70, 277-281, Copyright © 1990 by Endocrine Society

ARTICLES

Plasma norepinephrine kinetics, dopamine-beta-hydroxylase, and chromogranin-A, in hypothyroid patients before and following replacement therapy

R Polikar, B Kennedy, M Ziegler, DT O'Connor, J Smith and P Nicod
Division of Cardiology, University of California, San Diego Medical Center 92103.

Whether the increased plasma norepinephrine level reported in hypothyroidism is the result of impaired norepinephrine (NE) clearance or increased NE release by nerve terminals is unknown. We, therefore, measured plasma NE levels and clearance in 11 hypothyroid patients before [T4 index, 41.2 +/- 7.7 nmol/L (mean +/- SEM); TSH, 71.4 +/- 23.0 mU/L] and 4 +/- 0.5 months after thyroid replacement (T4 index, 136.4 +/- 24.4 nmol/L; TSH, 3.2 +/- 1.2 mU/L) and in 8 healthy volunteers. Plasma dopamine-beta-hydroxylase and chromogranin-A, which are coreleased with NE by sympathetic nerve endings, were also measured. Plasma NE was higher in the hypothyroid (2.37 +/- 0.24 nmol/L) than in the euthyroid state (1.86 +/- 0.24 nmol/L; P less than 0.02) or in the controls (1.87 +/- 0.27 nmol/L). Plasma clearance of NE, however, was not affected after thyroid replacement (hypothyroid, 2.08 +/- 0.31 L/min; euthyroid, 1.94 +/- 0.21 L/min; controls, 1.86 +/- 0.15 L/min). There was no significant change in plasma dopamine-beta- hydroxylase (hypothyroid, 720 +/- 139 nmol/mL.h; euthyroid, 553 +/- 97 nmol/mL.h) or plasma chromogranin-A (hypothyroid, 48.9 +/- 7.1 ng/mL; euthyroid, 42.9 +/- 5.3 ng/mL) after thyroid replacement. We conclude that the increased plasma NE in hypothyroid patients is not due to a change in plasma clearance, but is more likely secondary to increased NE release.

This article has been cited by other articles:

				J. E. Silva Thermogenic Mechanisms and Their Hormonal Regulation Physiol Rev, April 1, 2006; 86(2): 435 - 464. [Abstract] [Full Text] [PDF]

				F. Vargas, J. M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, and J. Garcia-Estan Vascular and renal function in experimental thyroid disorders Eur. J. Endocrinol., February 1, 2006; 154(2): 197 - 212. [Abstract] [Full Text] [PDF]

				J. B. Young, M. E. Burgi-Saville, U. Burgi, and L. Landsberg Sympathetic nervous system activity in rat thyroid: potential role in goitrogenesis Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E861 - E867. [Abstract] [Full Text] [PDF]

				S. Topaloglu, O. Y. Topaloglu, O. Ozdemir, M. Soylu, A. D. Demir, and S. Korkmaz Hyperthyroidism and Complete Atrioventricular Block: A Report of 2 Cases with Electrophysiologic Assessment Angiology, March 1, 2005; 56(2): 217 - 220. [Abstract] [PDF]

				A. Ichihara, H. Kobori, Y. Miyashita, M. Hayashi, and T. Saruta Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E224 - E231. [Abstract] [Full Text] [PDF]